Gelatin-methotrexate conjugate microspheres as a potential drug delivery system

Journal of Pharmaceutical Sciences

Volumn 95, Issue 9, 2006, Pages 1896-1908

  Pica, Karen ^a,b   Tchao, Ruy ^a   Ofner III, Clyde M ^a  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Conjugation; Controlled delivery; Enzymes; Hydrogels; Microspheres; Polymeric drug delivery systems

Indexed keywords

CATHEPSIN B; ETHANOLAMINE; GELATIN; GLUTARALDEHYDE; METHOTREXATE; MICROSPHERE; SCHIFF BASE;

ARTICLE; CROSS LINKING; DEGRADATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; IN VITRO STUDY;

EID: 33748933567     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20572     Document Type: Article

References (43)

1. Li FQ, Hu JH, Lu B, Yao H, Zhang WG. 2001. Ciprofloxacin-loaded bovine serum albumin microspheres: Preparation and drug-release in vitro. J Microencapsul 18:825-829.
2. Sahin S, Selek H, Ponchel G, Ercan MT, Sargon M, Hincal AA, Kas HS. 2002. Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres. J Contr Rel 82:345-358.
3. Liang H-C, Chang W-H, Lin K-J, Sung H-W. 2003. Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration: In Vitro and in vivo studies. J Biomed Mater Res 65A:271-282.
4. Vandelli MA, Romagnoli M, Monti A, Gozzi M, Forni F, et al. 2004. Microwave-treated gelatin microspheres as drug delivery system. J Contr Rel 96:67-84.
5. Iwanaga K, Yabuta T, Kakemi M, Morimoto K, Tabata Y, Ikada Y. 2003. Usefulness of microspheres composed of gelatin with various crosslinking density. J Microencapsul 20:767-776.
6. Park SB, Jeon YJ, Haam S, Park HY, Kim WS. 2004. Preparation of chitosan microspheres using membrane emulsification and its size modelling. J Microencapsul 21:539-552.
7. Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S. 2004. Chitosan microspheres as a potential carrier for drugs. Int J Pharm 274:1-33.
8. Dini E, Alexandridou S, Kiparissides C. 2003. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications. J Microencapsul 20:375-385.
9. Latha MS, Lal AV, Kumary TV, Sreekumar R, Jayakrishnan A. 2000. Progesterone release from glutaraldehyde cross-linked casein microspheres: In vitro studies and in vivo response in rabbits. Contraception 61:329-334.
10. Santinho AJ, Ueta JM, Freitas O, Pereira NL. 2002. Physicochemical characterization and enzymatic degradation of casein microcapsules prepared by aqueous coacervation. J Microencapsul 19:549-558.
11. Aubert-Pouessel A, Venier-Julienne MC, Clavreul A, Sergent M, Jollivet C, Montero-Menei CN, Garcion E, Bibby DC, Menei P, Benoit JP. 2004. In vitro study of GDNF release from biodegradable PLGA microspheres. J Contr Rel 95:463-475.
12. Gavini E, Chetoni P, Cossu M, Alvarez MG, Saettone MF, Giunchedi P. 2004. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: In vitro/in vivo studies. Eur J Pharm Biopharm 57:207-212.
13. Fernandez-Carballido A, Herrero-Vanrell R, Molina-Martinez IT, Pastoriza P. 2004. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro. Int J Pharm 279:33-41.
14. Uchida M, Jin Y, Natsume H, Kobayashi D, Sugibayashi K, Morimoto Y. 2002. Introduction of poly-L-lactic acid microspheres into the skin using supersonic flow: Effects of helium gas pressure, particle size and microparticle dose on the amount introduced into hairless rat skin. J Pharm Pharmacol 54:781-790.
15. Ehtezazi T, Washington C. 2000. Controlled release of macromolecules from PLA microspheres: Using porous structure topology. J Contr Rel 68:361-372.
16. Ma J, Chen D, Tian Y. 2001. A modified method for preparation of adriamycin carried by magnetic albumin microspheres. J Tongji Med Univ 21:233-235.
17. Hsu W, Lesniak MS, Tyler B, Brem H. 2005. Local delivery of interleukin-2 and adriamycin is synergistic in the treatment of experimental malignant glioma. J Neuro-Oncol 74:135-140.
18. Liang LS, Jackson J, Min W, Risovic V, Wasan KM, Burt HM. 2004. Methotrexate loaded poly(L-lactic acid) microspheres for intra-articular delivery of methotrexate to the joint. J Pharm Sci 93:943-956.
19. Jayakrishnan A, Knepp WA, Goldberg EP. 1994. Casein microspheres: Preparation and evaluation as a carrier for controlled drug delivery. Int J Pharm 106:221-228.
20. Liu Z, Cheung R, Wu XY, Ballinger JR, Bendayan R, Rauth AM. 2001. A study of doxorubicin loading onto and release from sulfopropyl dextran ion-exchange microspheres. J Contr Rel 77:213-224.
21. Mallery SR, Pei P, Kang J, Ness GM, Ortiz R, Touhalisky JE, Schwendeman SP. 2000. Controlled-release of doxorubicin from poly(lactide-coglycolide) microspheres significantly enhances cytotoxicity against cultured AIDS-related Kaposi's sarcoma cells. Anticancer Res 20:2817-2825.
22. Hao X, Cheng G, Zou M, Sun J, Cui F. 2004. Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice. Pharmazie 59:709-712.
23. Muvaffak A, Gurhan I, Hasirci N. 2004. Cytotoxicity of 5-fluorouracil entrapped in gelatin microspheres. J Microencapsul 21:293-306.
24. Menei P, Venier MC, Gamelin E, Saint-Andre J-P, Hayek G, Jadaud E, Fournier D, Mercie P, Guy G, Benoit J-P. 1999. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: A pilot study. Am Cancer Soc 86:325-330.
25. Okada H, Toguchi H. 1995. Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst 12:1-99.
26. Ryser H-P, Shen W-C. 1980. Conjugation of methotrexate to poly (L-lysine) as a potential way to overcome drug resistance. Cancer 45:1207-1211.
27. Minko T, Kopeckova P, Pozharov V, Kopecek J. 1998. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J Contr Rel 54:223-233.
28. Kim C-K, Oh Y-K. 1988. Development of hydrophilic human serum albumin microspheres using a drug-albumin conjugate. Int J Pharm 47:163-169.
29. Devineni D, Blanton CD, Gallo JM. 1995. Preparation and in vitro evaluation of magnetic microsphere-methotrexate conjugate drug delivery systems. Bioconjug Chem 6:203-210.
30. Leo E, Cameroni R, Forni F. 1999. Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates. Int J Pharm 180:23-30.
31. Mitra S, Gaur U, Ghosh PC, Maitra AN. 2001. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Contr Rel 74:317-323.
32. Narayani R, Rao KP. 1996. Biodegradable microspheres using two different gelatin drug conjugates for the controlled delivery of methotrexate. Int J Pharm 128:261-268.
33. Narayani R, Panduranga Rao K. 1996. Solid tumor chemotherapy using injectable gelatin microspheres containing free methotrexate and conjugated methotrexate. Int J Pharm 142:25-32.
34. Liu Z, Bendayan R, Wu XY. 2001. Triton-X-100-modified polymer and microsphere for reversal of multidrug resistance. J Pharm Pharmacol 53:779-787.
35. Pica K, Ofner CM III. The importance of capping and stabilizing glutaraldehyde crosslinked gelatin microspheres. unpublished results.
36. Lah TT, Cercek M, Blejec A, Kos J, Gorodetsky E, Somers R, Daskal I. 2000. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: Comparison with cathepsin D, cathepsin L, and other clinical indicators. Clin Cancer Res 6:578-584.
37. Barrett AJ, Kirschke H. 1981. Cathepsin B, Cathepsin H, and Cathepsin L. In: Lorand L, editor. Methods in Enzymology, New York: Academic Press.
38. Ofner CM III, Pica K, Bowman BJ, Chen C-S. 2006. Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates. Int J Pharm 308:90-99.
39. Riebeseel K, Biedermann E, Loser R, Breiter N, Hanselmann R, Mulhaupt R, Unger C, Kratz F. 2002. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: Synthesis, characterization, and structure-activity relationships in vitro and in vivo. Bioconjug Chem 13:773-785.
40. Hermanson GT. 1996. Bioconjugate Techniques, San Diego: Academic Press. pp 134-136 & 185.
41. Bowman BJ, Ofner CM III. 2000. Characterization and in vitro methotrexate release from methotrexate/gelatin conjugates of opposite conjugate bond polarity. Pharm Res 17:1309-1315.
42. Pica K. 2005. The effect of drug load to extend methotrexate release from gelatin-methotrexate conjugates and conjugated microspheres, PhD thesis, University of the Sciences in Philadelphia.
43. Nuernberg B, Kohlbrenner M, Faulkner R, Furst DE. 1989. Rapid quantitation of methotrexate and its metabolites in human serum, urine and bile, using solid-phase extraction and high-performance liquid chromatography. J Chromatogr 487:476-482.